Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

NCT02803437 · clinicaltrials.gov ↗

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG: Radium-223 dichloride (Xofigo, BAY 88-8223)

Sponsor

Bayer